• BVI heads to ESCRS 2026 with a comprehensive program centered on innovation, education and surgeon collaboration.
• European launch of Virtuoso and global availability of the complete ISOPURE SERENITY portfolio highlight a congress agenda featuring wet labs, educational sessions and peer-to-peer clinical engagement.

WALTHAM, Mass., August 19^th, 2026 — As the global ophthalmic community turns its attention to London for the 2026 European Society of Cataract and Refractive Surgeons (ESCRS) Congress, BVI, a leading global ophthalmic device company, is preparing to showcase how advanced technology, expanded cataract solutions, surgeon education and clinical collaboration come together to help shape the future of ophthalmic surgery.

Throughout the meeting, BVI will welcome surgeons, and industry partners to experience the company’s latest technologies through live demonstrations, hands-on wet labs, educational sessions and peer-to-peer discussions, reflecting its continued commitment to supporting surgeons beyond the operating room.

A centerpiece of BVI’s participation will be the European launch of Virtuoso, the company’s next-generation phacoemulsification platform. Designed to enhance workflow, usability and surgical performance, Virtuoso represents BVI’s continued investment in technologies that enable surgeons operate with greater confidence, efficiency and control.

The Virtuoso launch will culminate in a forum where surgeons, industry leaders and early clinical users will discuss emerging technologies within ophthalmic surgery, the development journey behind the platform and initial clinical experience, providing attendees with a firsthand look at its role in advancing cataract surgery.

“ESCRS represents one of the most important opportunities each year to engage directly with the global ophthalmic community,” said Andy Chang, Chief Commercial Officer of BVI. “This year’s program reflects our commitment to advancing ophthalmic surgery through the launch of innovative technologies, expanded cataract solutions and meaningful clinical collaboration with our surgeons.  Starting with Virtuoso, ISOPURE SERENITY and our comprehensive portfolio of surgical consumables, we’re demonstrating how BVI continues to build a comprehensive cataract surgery portfolio that support surgeons across every stage of cataract surgery and beyond.”

BVI will also showcase the global availability of the complete ISOPURE SERENITY line, reinforcing the company’s commitment to providing surgeons with a comprehensive cataract surgery portfolio. Designed to expand everyday vision while maintaining the visual quality and familiar surgical experience expected from a monofocal IOL, the portfolio provides surgeons with greater choice across a broad range of patient needs.

In addition to the Virtuoso launch and ISOPURE SERENITY portfolio showcase, BVI’s ESCRS program will include:

• Hands-on wet labs featuring Virtuoso and complementary surgical technologies
• Educational sessions led by BVI’s network, including members of its recently established EU Surgical Leadership Council
• Advisory board discussions focused on the future of ophthalmic surgery
• Peer-to-peer clinical discussions highlighting early surgical experience and best practices

These activities reflect BVI’s broader commitment to partnering with surgeons through education, collaboration and innovation while creating opportunities to exchange knowledge, share clinical perspectives and advance ophthalmic care together.

“Innovation doesn’t end with the introduction of a new technology,” said Mikhail Boukhny, Chief Technology Officer of BVI. “It comes to life when engineers, clinicians and surgeons collaborate to solve real-world challenges. ESCRS provides an ideal platform to exchange ideas, learn from early clinical experience and continue advancing technologies that support better surgical outcomes.”

Attendees are invited to visit Booth D.136 throughout the congress to experience BVI’s latest technologies, participate in educational activities and connect with members of the global BVI team.

***

About BVI

BVI® is a leading innovator in eye health, with a long-standing legacy of shaping ophthalmic care through advanced technology. Building on nearly nine decades of expertise, from foundational surgical instruments to premium intraocular lenses and next-generation platforms, BVI partners closely with surgeons to deliver technology designed to support surgical performance and patient care. Serving surgical teams in more than 90 countries, BVI is committed to improving vision for patients worldwide.

To learn more about BVI and its mission to advance the future of vision, visit https://www.bvimedical.com

Press Contact